
Funding
Dognosis raises undisclosed sum from Accel, Caffeinated
By Abha Lohia · Editor ·
pre-seedBengaluruFounded 2024
- Dognosis uses trained dogs and AI to detect cancer from human breath samples
- It raised an undisclosed amount from Accel India and Caffeinated Capital, after a $1.5M pre-seed in 2024
- Phase 3 trial with 10,000 people is underway; the company plans to launch a home test in India next year
What happened
- Dognosis uses dogs (beagles, labradors, Dutch shepherds) to sniff cancer from human breath.
- Patients breathe into masks sent to the company's facility; dogs are exposed to samples in a game-like setting.
- Sensors and AI interpret dog signals (movement, respiration, brain activity) to detect cancer without imaging or blood tests.
- The company raised an undisclosed sum recently from Accel India and Caffeinated Capital.
- It had previously raised a $1.5M pre-seed round in 2024.
- A Phase 2 study published in the Journal of Clinical Oncology reported ~90% sensitivity for early-stage cancers across 7 groups.
- Phase 3 trial started in April 2026 with 10 hospitals across India, planning to recruit ~10,000 people over 12 months.
- Dogs trained on 10 cancer types identified an 11th type not encountered before.
Why it matters
- India has the third-highest prevalence of new cancer cases globally, with IARC estimating 1.5M new cases in 2024.
- Only 1.9% of Indian women surveyed had ever screened for cervical cancer; rates for breast and oral cancer are below 1.2%.
- Roughly 1 in 10 Indians is at risk of developing cancer before age 75.
- New Jersey startup SpotitEarly reported similar canine cancer-detection trial results but has not commercialised yet.
The business
- Dognosis is a 2-year-old startup operating on a 2-acre farm outside Bengaluru.
- It uses dogs to detect cancer from human breath; patients send breath masks to the facility.
- Dogs work 30 minutes to 1 hour per day on a detection platform and are rewarded with treats.
- The company's technology includes DogSense BCI (brain-computer interface), DogOS ML suite, and SniffSpace olfactory workstation.
- It plans to launch an at-home multi-cancer prescreening test in India next year for a few thousand rupees.
- The test does not need Indian regulatory approval as it is a prescreening tool, not a diagnostic device.
The founders
Who put in money
- Accel India participated — Venture capital firm investing in Indian startups.
- Caffeinated Capital participated — San Francisco-based venture capital firm.
In numbers
$1.5MPre-seed round · 2024
~90%Phase 2 sensitivity · 2026
~10,000Phase 3 trial participants · 2026
30 min to 1 hourDogs' daily work time · 2026
>20Cancer types detected in Phase 2 · 2026
What happens next
- Launch at-home multi-cancer prescreening test in India in 2027 for a few thousand rupees.
- Aim to process 1 million tests per year, double canine workforce to 30, and halve turnaround time to 1 week.
- Eyeing a US facility by late 2027 or early 2028.
- If Phase 3 results hold, launch in Bengaluru next year, then expand across India via diagnostic chains and healthcare providers.
Earlier rounds
- 2024 · pre-seed · $1.5M
Up against
SpotitEarly
Words to know
- Phase 3 trial
- A large-scale clinical study to confirm a test or treatment's effectiveness and monitor side effects in a broad population.
- Sensitivity
- The ability of a test to correctly identify people who have a disease; higher sensitivity means fewer false negatives.
- Prescreening tool
- A test used to identify people who may have a disease before formal diagnosis, not requiring regulatory approval as a diagnostic device.
- BCI (Brain-Computer Interface)
- A technology that reads brain signals directly from the scalp using sensors, here used to interpret a dog's response to a scent.
Other articles talking about it
Terms in this story
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.
All startup news on 14 August 2026 →
Is this Dognosis? Get your “Featured on StopDown” badge →